Citation 91236

GUTHRIE,RW: BROSSI,A: MENNONA,FA: MULLIN,JG: KIERSTEAD,RW: GRUNBERG,E:. (1975). ELLIPTICINE DERIVATIVES.. 18()

Citation Details

Title	ELLIPTICINE DERIVATIVES.
Authors	GUTHRIE,RW: BROSSI,A: MENNONA,FA: MULLIN,JG: KIERSTEAD,RW: GRUNBERG,E:
Year	1975
Volume	18
Issue

Summary

Year: 1975

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-DIHYDRO-2-TOSYL-8-9-METHYLENEDIOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-DIHYDRO-2-TOSYL-8-9-METHYLENEDIOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-DIHYDRO-2-TOSYL-8-9-METHYLENEDIOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
4	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,6-ACETOXY-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,6-ACETOXY-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,6-ACETOXY-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
7	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-METHOXY:	INACTIVE
8	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-METHOXY:	INACTIVE
9	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-METHOXY:	ACTIVE
10	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-METHOXY:	ACTIVE
11	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-METHOXY:	ACTIVE
12	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-METHOXY:	ACTIVE
13	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-METHOXY:	ACTIVE
14	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-METHOXY:	ACTIVE
15	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE	INACTIVE
16	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE	INACTIVE
17	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE	ACTIVE
18	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE	ACTIVE
19	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE	INACTIVE
20	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE	ACTIVE
21	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE	ACTIVE
22	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE	ACTIVE
23	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-CARBOXY-N-(1-ADAMANTYL):*	INACTIVE
24	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-CARBOXY-N-(1-ADAMANTYL):*	INACTIVE
25	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-CARBOXY-N-(1-ADAMANTYL):*	ACTIVE
26	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-CARBOXY-N-(1-ADAMANTYL):*	ACTIVE
27	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
28	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
29	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
30	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
31	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
32	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
33	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-2-5-11-TRIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
34	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-2-5-11-TRIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
35	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-2-5-11-TRIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
36	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-2-3-4-TETRAHYDRO-9-METHOXY-2-5-11-TRIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
37	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-HEXANOYL-OXY:*	INACTIVE
38	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-HEXANOYL-OXY:*	INACTIVE
39	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-HEXANOYL-OXY:*	INACTIVE
40	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-HEXANOYL-OXY:*	ACTIVE
41	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-ISO-PROPANOYL-OXY:*	INACTIVE
42	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-ISO-PROPANOYL-OXY:*	ACTIVE
43	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-ISO-PROPANOYL-OXY:*	ACTIVE
44	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-ISO-PROPANOYL-OXY:*	ACTIVE
45	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,9-HYDROXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
46	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,9-HYDROXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
47	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,9-HYDROXY-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
48	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-LAUROYL-OXY:*	ACTIVE
49	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-LAUROYL-OXY:*	ACTIVE
50	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-LAUROYL-OXY:*	ACTIVE
51	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-LAUROYL-OXY:*	ACTIVE
52	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-CARBOXY-ETHYL:*	INACTIVE
53	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-CARBOXY-ETHYL:*	ACTIVE
54	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-CARBOXY-ETHYL:*	INACTIVE
55	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ELLIPTICINE,9-CARBOXY-ETHYL:*	ACTIVE
56	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,9-METHOXY-6-(2-DIETHYL-AMINO-ETHYL)-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
57	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,9-METHOXY-6-(2-DIETHYL-AMINO-ETHYL)-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
58	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,9-METHOXY-6-(2-DIETHYL-AMINO-ETHYL)-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE
59	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,9-METHOXY-6-(2-DIETHYL-AMINO-ETHYL)-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	ACTIVE
60	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,9-METHOXY-6-(2-DIETHYL-AMINO-ETHYL)-5-11-DIMETHYL-6-(H)-PYRIDO-(4-3-B):*	INACTIVE

Citation 91236

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1